These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2831525)

  • 1. The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study.
    Edmonds D; Greminger P; Vetter W; Baumgart P; Vetter H
    Postgrad Med; 1988 Feb; Spec No():40-5. PubMed ID: 2831525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril as a first-step agent in essential hypertension: a comparative study with atenolol.
    Edmonds D; Greminger P; Locher R; Knorr M; Vetter H; Vetter W
    J Hypertens Suppl; 1986 Dec; 4(5):S406-9. PubMed ID: 3033180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of monotherapy with enalapril and atenolol in mild to moderate hypertension. The Canadian Enalapril Study Group.
    CMAJ; 1987 Nov; 137(9):803-8. PubMed ID: 2894890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
    Applegate WB; Phillips HL; Schnaper H; Shepherd AM; Schocken D; Luhr JC; Koch GG; Park GD
    Arch Intern Med; 1991 Sep; 151(9):1817-23. PubMed ID: 1888248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualizing antihypertensive therapy with enalapril versus atenolol: the Zurich experience.
    Edmonds D; Huss R; Jeck T; Mengden T; Schubert M; Vetter W
    J Hypertens Suppl; 1990 Sep; 8(4):S49-52. PubMed ID: 2258784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
    Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
    Nissinen A; Tuomilehto J
    Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
    Steiner SS; Friedhoff AJ; Wilson BL; Wecker JR; Santo JP
    J Hum Hypertens; 1990 Jun; 4(3):217-25. PubMed ID: 2194029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Russell AE; Elliott JM; Morris MJ
    J Hypertens Suppl; 1987 Dec; 5(5):S603-6. PubMed ID: 2832575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of the antihypertensive action of atenolol, enalapril and placebo: a randomized within-patient study using ambulatory blood pressure monitoring.
    Verdecchia P; Gatteschi C; Benemio G; Boldrini F; Guerrieri M; Porcellati C
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):570-4. PubMed ID: 2854116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.